INSPIRNA
Inspirna (formerly Rgenix) is a clinical-stage biopharmaceutical company developing first-in-class/best-in-class drug candidates that target critical cancer drivers. Our discovery platform leverages RNA biology to discover novel RNA dysregulated cancer drivers that can be targeted by small molecules and biologics. Clinical programs are first-in-class oral small molecules in development for patients with RAS mutant CRC (RGX-202; Phase 1b) as well as SCLC and NSCLC (RGX-104; Phase 1b/2)
INSPIRNA
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2010-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.inspirna.com
Total Employee:
11+
Status:
Active
Contact:
(646) 856-9261
Email Addresses:
[email protected]
Total Funding:
144.6 M USD
Technology used in webpage:
SPF Euro Amazon Google Apps For Business GoDaddy DNS AWS Global Accelerator Dropbox Business
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Eureka Therapeutics
Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.
MindMed
MindMed provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
IVERIC bio
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Vor Biopharma
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
X4 Pharmaceuticals
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Current Advisors List
Current Employees Featured
Founder
Investors List
The New York City Investment Fund
The New York City Investment Fund investment in Series D - Inspirna
Sixty Degree Capital
Sixty Degree Capital investment in Series D - Inspirna
Sofinnova Partners
Sofinnova Partners investment in Series D - Inspirna
Dreavent 6
Dreavent 6 investment in Series D - Inspirna
Novo Holdings
Novo Holdings investment in Series D - Inspirna
Sands Capital Ventures
Sands Capital Ventures investment in Series D - Inspirna
Vivo Capital
Vivo Capital investment in Series D - Inspirna
Lepu Medical
Lepu Medical investment in Series D - Inspirna
Lepu Medical
Lepu Medical investment in Series C - Inspirna
Alexandria Venture Investments
Alexandria Venture Investments investment in Series C - Inspirna
Official Site Inspections
http://www.inspirna.com Semrush global rank: 3.61 M Semrush visits lastest month: 3.96 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Inspirna"
Inspirna – The Future of Cancer Therapy
Jan 4, 2024 · Inspirna, Inc. is a privately-held clinical-stage biopharmaceutical company focused on the discovery and development of novel cancer drugs that target key pathways in cancers …See details»
Our Company - Inspirna
Inspirna, previously known as Rgenix, is a privately-held clinical-stage biopharmaceutical company focused on the discovery and development of novel cancer drugs that target key pathways in cancers of high unmet need.See details»
Careers – Inspirna
Inspirna, Inc. - LinkedIn
Inspirna, Inc. | 2,271 followers on LinkedIn. Converting cancer to a manageable, chronic condition | Inspirna, Inc., is a privately-held clinical-stage biopharmaceutical company focused on the...See details»
Inspirna Company Profile 2024: Valuation, Funding & Investors
Inspirna is headquartered in New York, NY. What is the size of Inspirna? Inspirna has 35 total employees. What industry is Inspirna in? Inspirna’s primary industry is Drug Discovery. Is …See details»
Inspirna - Crunchbase Company Profile & Funding
Inspirna (formerly Rgenix) is a clinical-stage biopharmaceutical company developing first-in-class/best-in-class drug candidates that target critical cancer drivers. Our discovery platform …See details»
RGENIX Announces Company Name Change to Inspirna and …
Sep 30, 2021 · Inspirna, Inc., is a privately-held clinical-stage biopharmaceutical company focused on the discovery and development of novel cancer drugs that target key pathways in …See details»
Inspirna - Products, Competitors, Financials, Employees, …
Inspirna is a clinical-stage biopharmaceutical company with a focus on the discovery and development of novel cancer drugs.See details»
Agreement with Inspirna for Ompenaclid | Merck
Jan 4, 2024 · Merck, a leading science and technology company, today announced a licensing agreement with Inspirna, Inc. (New York, NY) for ompenaclid (RGX-202), a first-in-class oral inhibitor of the creatine transport …See details»
Inspirna to Present at the 42nd Annual J.P. Morgan Healthcare ...
Jan 4, 2024 · Inspirna, Inc., is a privately-held clinical-stage biopharmaceutical company focused on the discovery and development of novel cancer drugs that target key pathways in cancers …See details»
Our Science – Inspirna
Inspirna has developed the unique expertise to discover novel and actionable cancer drivers that affect large patient populations. We conduct comprehensive studies including genomic, transciptomic, proteomic and metabolomic …See details»
Usman Azam - CEO at Inspirna - The Org
With over two decades of drug development experience, Dr. Azam most recently served as Chief Executive Officer of Empyrean Neuroscience, a genetic engineering company advancing a …See details»
Inspirna Announces Clinical Collaboration with Bristol Myers …
Nov 4, 2021 · Inspirna, Inc., is a privately-held clinical-stage biopharmaceutical company focused on the discovery and development of novel cancer drugs that target key pathways in cancer …See details»
Inspirna Company Profile - Office Locations, Competitors, Revenue ...
See insights on Inspirna including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Inspirna - Overview, News & Similar companies | ZoomInfo.com
Inspirna contact info: Phone number: (646) 856-9261 Website: www.inspirna.com What does Inspirna do? Inspirna, Inc., is a privately-held clinical-stage biopharmaceutical company …See details»
News & Events - Inspirna
Aug 31, 2015 · Inspirna Announces Clinical Collaboration with Bristol Myers Squibb to Study RGX-104 in Combination with Yervoy® (ipilimumab) for Treatment of Metastatic Endometrial …See details»
Inspirna, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Nov 1, 2024 · Explore Inspirna, Inc. with its drug pipeline, therapeutic area, technology platform, 5 clinical trials, 39 news, and 14 literature, Disease Domain:Neoplasms, Hemic and Lymphatic …See details»
Inspirna Raises $50 Million in Series D Financing
Jul 11, 2022 · Inspirna, Inc., is a privately-held clinical-stage biopharmaceutical company focused on the discovery and development of novel cancer drugs that target key pathways in cancers …See details»
Inspirna CEO and Key Executive Team | Craft.co
Inspirna's Chief Executive Officer is Usman Azam. Other executives include Robert Wasserman, Chief Medical Officer; Masoud Tavazoie, Advisor & Co-Founder and 7 others. See the full …See details»
Inspirna - VentureRadar
Inspirna (formerly Rgenix) is a clinical-stage biopharmaceutical company developing first-in-class/best-in-class drug candidates that target critical cancer drivers. Our discovery platform …See details»